Multiomics Market Demonstrates Long-Term Growth Potential At 15.6% CAGR

The multiomics field is gaining significant traction as it integrates various biological data layers to provide comprehensive insights into health, disease, and agriculture. This market is set for notable expansion, fueled by technological advancements and growing interest in personalized applications. Here, we explore the current market size, key players, trends, and segmentations shaping the future of multiomics.

Projected Market Size and Expansion of the Multiomics Industry
The multiomics market is anticipated to grow rapidly, reaching a valuation of $8.07 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 15.6% over the forecast period. Several factors are propelling this growth, including innovations in multiomics platforms, a heightened demand for personalized medicine, and the increasing adoption of AI-driven analytics. Additionally, the expanding use of metabolomics in clinical environments and the broader application of multiomics in precision agriculture are contributing to the market's upward trajectory. Noteworthy trends include the rising uptake of single-cell multiomics, deeper integration of multiple biological data layers, advancements in early disease detection, expanded utilization in drug discovery processes, and growing agricultural genomics applications.

The multiomics market size has grown rapidly in recent years. It will grow from $3.85 billion in 2025 to $4.52 billion in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to rise in genomic sequencing adoption, early development of transcriptomics tools, increased availability of proteomic analysis platforms, expansion of biomarker identification research, growth in biological data generation.

Download a free sample of the multiomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Organizations Driving the Multiomics Market
The multiomics sector features a diverse array of key players driving innovation and market growth. Some of the prominent companies include Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton dic*kinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam Limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, and BGI Group.

In a strategic move in July 2024, Belgium-based Anacura acquired OHMX.bio, a Ghent University spin-off specializing in advanced integrative "-omics" technologies. This acquisition focuses on boosting Anacura's capabilities in multiomics to strengthen its drug discovery and diagnostics platforms. OHMX.bio combines next-generation sequencing, bioinformatics, and multi-omic analyses to accelerate the development of biologics and advanced therapies such as mRNA vaccines and CAR-T cells.

View the full multiomics market report:
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Influencing the Multiomics Landscape
One significant trend is the development of advanced single-cell multiomics platforms that allow researchers to conduct large-scale studies without compromising sample integrity. These platforms merge multiple omics layers with artificial intelligence, enabling comprehensive data analysis through sophisticated machine learning algorithms.

For example, in February 2023, Becton dic*kinson and Company introduced the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This system enhances scientists' capabilities by allowing them to isolate, barcode, and analyze a much larger number of single cells-up to eight times more than earlier models. Its design ensures minimal sample loss and offers the flexibility to analyze multiple samples and different cell types simultaneously, including stem cells and cancer cells, thereby accelerating research productivity and insight generation.

Comprehensive Segmentation Within the Multiomics Market
The multiomics market is categorized across several important segments to better understand its scope and applications:

1) By Type: Single-Cell Multiomics and Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, and Other Applications
4) By End User: Academic and Research Organizations, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Other End Users

Within these segments, further subcategories include:

- Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, and Single-Cell Metabolomics
- Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, and Metabolomics

This detailed segmentation aids in mapping the diverse uses and technological aspects of multiomics, highlighting its growing importance across biomedical and agricultural research.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.